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Conclusions: Patients undergoing secondary interventions for recur-
rent RAS have comparable outcomes as those for primary interventions.
These data suggest that repeated endovascular procedures for renal artery
restenosis can be safely undertaken while maintaining similar expectations
for clinical improvement.
Comparing Computed Tomographic Angiography vs Ultrasound Vein
Mapping in Evaluating the Suitability of the Great Saphenous Vein for
Distal Bypass
Omar P. Haqqani, Benjamin W. Botsford, Prakhar K. Agarwal, Mark D.
Iafrati, William C. Mackey, James M. Estes. Tufts University Medical
Center, Boston, Mass
Introduction and objectives: Although computed tomography an-
giography (CTA) is commonly used preoperatively to determine arterial anat-
omy, duplex ultrasound (DUS) vein mapping is frequently used to determine
the suitability of bypass conduits. The purpose of this study was to determine the
correlation between DUS and CTA in the evaluation of the great saphenous
vein (GSV) with respect to diameter and usability in lower extremity bypasses.
Methods: A single-center retrospective review identified patients who
had both CTA and DUS in preparation for lower extremity bypass, between
June 2001 and February 2012. DUS reports included GSV diameter at the
saphenofemoral junction, midthigh, knee, and midcalf. CTAs were reviewed
independently by two vascular surgeons who were blinded to the DUS and
surgical findings. The interobserver variability was analyzed using Pearson
correlation. The relationship between CTA and DUS measurements was
compared at each anatomic level using correlation coefficients. The predic-
tive ability of CTA was analyzed using the Fisher exact test.
Results: Sixteen patients (9 men [56.3%]) underwent CTA and DU in
preparation for lower extremity bypass (23 limbs). The average patient age
was 65.1 years, 10 (62.5%) were diabetic, and three (18.8%) had a history of
DVT or phlebitis. A high degree of correlation existed between the two
surgeons’ GSV measurements using CTA (r  .09996, P  .0001), and a
strong correlation existed between CTA and DUS GSV measurements (r
.07306, P .0001). CTA assessment of GSV usability correlates with actual
usage as conduit (P .0099) with a sensitivity of 92% and sensitivity of 80%.
Conclusions:CTA can be accurately used to evaluate the diameter and
usability of the GSV for lower extremity revascularization, eliminating the
need for additional testing.
Impact of Severe Chronic Kidney Disease on Outcomes of Endovascu-
lar Intervention for Infrainguinal Peripheral Arterial Disease
Virendra I. Patel, Shankha Mukhopadhyay, Julie M. Guest, Mark F. Conrad,
Glenn M. LaMuraglia, Christopher J. Kwolek, Richard P. Cambria. Mas-
sachusetts General Hospital, Boston, Mass
Introduction and objectives: Patients with class 4 and 5 chronic kidney
disease (CKD) and peripheral vascular disease (PVD) are at increased risk of
major adverse limb events (MALE), amputation, and death. We evaluated the
effect of CKD on outcomes after peripheral vascular intervention (PVI).
Methods: All primary PVIs performed at a single institution (January
2002-December 2009) were included. End points were defined by Society
for Vascular Surgery (SVS) objective performance goals for critical limb
ischemia (J Vasc Surg 2009;50:1462-73): death, reintervention, amputa-
tion, death/amputation, and MALE (reintervention or amputation).
Results: A total of 879 PVIs were performed, with CKD in 125
(14%). CKD patients were significantly (P  .05) more likely to have
diabetes (64% vs 46%), critical ischemia (72% vs 11%), multilevel PVI
(34% vs 19%), and tibial intervention (35% vs 20%). Distribution of
Trans-Atlantic Inter-Society Consensus C and D lesions were similar
(19% CKD vs 15%; P  .02). CKD was not associated with SVS high-risk
criteria (age 80 years and CLI; 14% CKD vs 11%; P  .3). CKD
predicted 30-day reintervention (odds ratio [OR], 2.3; confidence inter-
val [CI], 1.5-4; P  .005), amputation/death (OR, 3.1; CI, 1.1-9; P 
.004), and MALE (OR, 2.8; CI, 1.3-6.1; P  .004) independent of CLI.
On Cox regression, CKD increased late death (HR, 2.4; CI, 1.8-3.2; P
.01), amputation (HR, 2.1; CI, 1.1-3.9; P  .002), and death/amputa-
tion (HR, 1.8; CI, 1.3-2.4; P  .004), with no increase in reintervention
or MALE. On Kaplan-Meier analysis, CKD was significantly (log-rank,
P  .05) associated with death (31%  4% vs 7%  1%), amputation
(14%  3% vs 3%  1%), death/amputation (31%  4% vs 9%  1%), and
MALE (40%  5% vs 26%  2%) at 1 year. Freedom from reintervention
was similar at 1 year (70%  5% severe CKD vs 75%  2%; P  .23).
Conclusions: Current performance goals have excluded patients with
severe CKD, yet CKD independently predicts early and late adverse events
after PVI, in particular, excessive mortality. CKD should figure prominently
in clinical decision making for patients with PVD.
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Introduction and objectives: To compare clinical outcomes and
long-term durability of aortoiliac (AI) and femoropopliteal (FP) endovascu-
lar (EV) and open interventions for disabling claudication (DC), and to
determine the effect of Trans-Atlantic Inter-Society Consensus (TASC
classification (A/B vs C/D) on outcomes.
Methods: Patients with Rutherford 3 DC, who had open (n 
93,107 limbs), or EV interventions (n  167, 206 limbs) between June
2001 and December 2009 were grouped as AI open (n  47), AI
EV-A/B (n 91), AI EV-C/D (n 35), FP open (n 60), FP EV-A/B
(n  29), and FP EV-C/D (n  51). Patency, sustained clinical success
(clinical improvement, freedom from target extremity revascularization),
and secondary clinical success (with target extremity revascularization)
were calculated.
Results: There were more smokers (79% vs 57%, P  .001) and less
diabetes mellitus (25% vs 37%, P  .003) in open and less CAD in FP
EV-A/B (24% vs 50%, P  .0009). Mean follow-up was 48  24 months.
Patency and clinical success rates were similar in iliac subgroups (Table). FP
EV-C/D and FP open groups fared significantly worse than FP EV-A/B. In AI,
9% in open and 15% in EV groups had reinterventions; 1% (n  2) needed
bypass. In FP EV-A/B, 17% needed reinterventions, 3% had bypass; in FPFig.
Fig.
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EV-C/D and FP open, these were 41% and 32% for reinterventions and 20%
and 17% for a new bypass, respectively. The overall amputation rate was 1.2%.
Conclusions: Clinical benefit for DC is excellent in AI, irrespective of
TASC, and in FP segment with TASC A/B. Acceptable durability in FP
TASC C/D can be achieved, however reinterventions are frequently needed,
irrespective of type of revascularization.
Table. Primary (PP), secondary patency (SP), sustained clinical success
(SusClSuc) and secondary clinicals
Variable
PP SP SusClSuc SecClSuc
24 mo 48 mo 24 mo 48 mo 24 mo 48 mo 24 mo 48 mo
(%) (%) (%) (%) (%) (%) (%) (%)
AI open
(n  47)
91  4 91  4 94  4 94  4 91  4 91  4 96  3 96  3
AI A/B
(n  91)
94  3 87  4 98  2 98  2 90  3 75  5 98  2 98  2
AI C/D
(n  35)
100 100 100 100 100 100 100 100
P .425 .206 .118 .429
FP open
(n  60)
64  6 54  7 75  6 71  6 64  6 54  7 86  5 80  6
FP A/B
(n  29)
93  5 83  8 97  3 97  3 93  5 83  8 100 100
FP C/D
(n 51)
46  7 46  7 68  7 63  7 46  7 46  7 82  6 82  6
P .001 .005 .002 .043
A Comparison of Rigid vs Soft Dressings in the Healing of Below Knee
Amputations (BKA)
Sarah Shine, Brandon J. Sumpio, David Mahler, Bauer E. Sumpio. Yale
University School of Medicine, New Haven, Conn
Introduction and objectives: There is no standard protocol for the
selection of surgical dressings after a below knee amputation (BKA). The
purpose of this study was to compare rigid dressings with soft dressings on
the healing times of BKA. We hypothesized that rigid dressings would
facilitate faster wound healing and residual limb maturation by minimizing
postsurgical edema and pain, preventing knee flexion contracture, and
protecting the residual limb from trauma.
Methods: Our retrospective analysis compared 151 patients who un-
derwent BKA from 2000 to 2012 at Yale New Haven Hospital, after which
60 patients received soft dressings and knee immobilizers (soft) after the
amputation, and 92 were placed in a rigid plastic or plaster prosthesis (rigid).
Demographics and outcomes, including time between amputation and
initial casting of prosthesis, were compared.
Results: Age and diabetic status was not statistically different between
the soft (61.0 years, 82.8% with diabetes) and rigid groups (58.6 years,
78.0% with diabetes). After BKA, the rigid dressing group demonstrated
significantly decreased time spans from amputation to initial casting, as
shown by the Fig (P  .02 by log-rank and Wilcoxon test) and the Table.
After 60 days, 58.24% of the rigid group was cast, compared with 38.33% of
soft group (P  .03 by t test).
Conclusions: Use of a rigid dressing after a BKA significantly short-
ened the time to healing, as assessed by the time to casting. Use of a rigid
prosthesis allows for consistent dressing changes of the healing BKA stump
while facilitating inspection of the limb.
Table. Days to casting
Type of dressing Median Mean
Percentile
25th 75th
Rigid 43 76 30 102
Soft 75 127 41 127
Open Surgical Revision of Unfavorable Vein Graft Lesions Provides a
More Durable Repair
Rodney P. Bensley, Jr, Michelle C. Martin, Jeremy D. Darling, Ruby C. Lo,
Margriet Fokkema, Mark C. Wyers, Allen D. Hamdan, Marc L. Schermer-
horn. Beth Israel Deaconess Medical Center, Boston, Mass
Introduction and objectives: Prior studies have demonstrated that
favorable vein graft lesions (single, 2-cm lesions in grafts older than 3
months) can be treated successfully with percutaneous transluminal angio-
plasty (PTA) and other endovascular techniques. However, the optimum
treatment method for unfavorable lesions is not yet clear.
Methods: This was a retrospective review (2000-2011) of patients
undergoing PTA or open revision of failing infrainguinal vein grafts. Demo-
graphics, comorbidities, lesion characteristics, and procedural information
were recorded. Failure was defined as restenosis by duplex scan, occlusion,
redo PTA, surgical revision, or amputation. Cox proportional hazard models
and life-table analyses were performed. We report 12-month failure rates.
Results: We studied 176 failing vein grafts in 169 patients: 84 grafts
underwent PTA and 92 open revision. Mean age was similar between PTA
and open revision (67.5 vs 69.5 years, P  .28) as was the proportion with
asymptomatic failing grafts (54.7% vs 52.1%, P  .76). Grafts undergoing
PTA were more likely to be unfavorable (64.3% vs 45.7%, P  .01) with
multiple lesions (32.1% vs 14.1%, P  .01) and lesions 2 cm (44.0% vs
21.7%, P  .01). Overall, PTA failed more than open revision (65.4% vs
44.5%, P .01). Freedom from PTA failure was greater in favorable lesions
compared with unfavorable (52.3% vs 30.5%, P  .01). Favorability had no
influence on freedom from open revision failure (65.7% vs 70.5%, P .072).
Among favorable lesions, there was no difference in freedom from failure
between PTA and open revision (52.3% vs 65.7%, P  .68). However,
unfavorable lesions fared much worse after PTA (30.5% vs 70.5%, P  .01;
Fig). There were no predictors of open revision failure. Unfavorable lesions
(HR, 2.17 [1.16-4.00]; P .01) predicted PTA failure, primarily driven by
bypass graft age  3 months (HR, 2.84 [1.36-5.93]; P  .01).
Conclusions: Open revision of unfavorable vein graft lesions provides
greater freedom from failure and should be the primary therapy for failing
vein grafts with unfavorable lesions. Favorable vein grafts should continue to
be treated endovascularly.
Thirty-Day Readmission Following Lower Extremity Bypass for Crit-
ical Limb Ischemia (CLI) in the PREVENT III Cohort
James T. McPhee,1 Louis L. Nguyen,1 Karen J. Ho,1 Charles K. Ozaki,1
Michael S. Conte,2 Michael Belkin1. 1Brigham and Women’s Hospital,
Boston, Mass; 2University of California San Francisco, San Francisco, Calif
Introduction and objectives: Hospital readmission after lower ex-
tremity bypass (LEB) is an economic burden and a focal point for policyFig.
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